Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Aug;151(2):601-10.

Presenilin-1 is associated with Alzheimer's disease amyloid

Affiliations

Presenilin-1 is associated with Alzheimer's disease amyloid

T Wisniewski et al. Am J Pathol. 1997 Aug.

Abstract

Mutations in presenilin (PS)-1 and -2, located on chromosome 14 and 1 respectively, are the major association with early-onset familial Alzheimer's disease (FAD). FAD has also been linked to mutations in the amyloid beta precursor protein (beta PP), and the presence of the apolipoprotein E4 allele is a risk factor for late-onset AD. The role of PS in FAD and in sporadic AD is unclear. We previously reported the presence of a PS-1 carboxyl-terminal epitope in neuritic plaques (Wisniewski T, Palha JA, Ghiso J, Frangione B: S182 protein in Alzheimer's disease neuritic plaques. Lancet 1995, 346:1366). In the present study, we examined a number of biochemically different cerebral and systemic amyloidoses, finding the PS-1 carboxy epitope only in association with amyloid beta (A beta) lesions. We confirm the presence of this epitope ultrastructurally in neuritic plaques. In addition, biochemical and amino acid sequence data are presented for an association of the 18-kd carboxy fragment of PS-1 with neuritic plaques with a start at residue 300. Three of the proteins with linkage to AD have now been found as components of neuritic plaques. It remains to be determined whether all of these proteins are involved in the same or different pathological pathway(s) and which of these proteins is the most important for the common, late-onset form of AD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nature. 1991 Feb 21;349(6311):704-6 - PubMed
    1. Neurobiol Dis. 1996;3(3):159-68 - PubMed
    1. J Histochem Cytochem. 1992 Jul;40(7):1011-20 - PubMed
    1. Mol Neurobiol. 1994 Feb;8(1):49-64 - PubMed
    1. Lancet. 1995 Apr 15;345(8955):956-8 - PubMed

Publication types